相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Impact of Venetoclax and Azacitidine in Treatment-Naive Patients with Acute Myeloid Leukemia and IDH1/2 Mutations
Daniel A. Pollyea et al.
CLINICAL CANCER RESEARCH (2022)
Ivosidenib and Azacitidine in IDH1-Mutated Acute Myeloid Leukemia
Pau Montesinos et al.
NEW ENGLAND JOURNAL OF MEDICINE (2022)
Validation and refinement of the revised 2017 European LeukemiaNet genetic risk stratification of acute myeloid leukemia
Tobias Herold et al.
LEUKEMIA (2020)
Loss of TET2 Affects Proliferation and Drug Sensitivity through Altered Dynamics of Cell-State Transitions
Leanna Morinishi et al.
CELL SYSTEMS (2020)
The R package Rsubread is easier, faster, cheaper and better for alignment and quantification of RNA sequencing reads
Yang Liao et al.
NUCLEIC ACIDS RESEARCH (2019)
The prognostic impact of tet oncogene family member 2 mutations in patients with acute myeloid leukemia: a systematic-review and meta-analysis
Ruiqi Wang et al.
BMC CANCER (2019)
Rational Targeting of Cooperating Layers of the Epigenome Yields Enhanced Therapeutic Efficacy against AML
Cihangir Duy et al.
CANCER DISCOVERY (2019)
Invariant phenotype and molecular association of biallelic TET2 mutant myeloid neoplasia
Hassan Awada et al.
BLOOD ADVANCES (2019)
Cooperative Epigenetic Remodeling by TET2 Loss and NRAS Mutation Drives Myeloid Transformation and MEK Inhibitor Sensitivity
Hiroyoshi Kunimoto et al.
CANCER CELL (2018)
Clearance of Somatic Mutations at Remission and the Risk of Relapse in Acute Myeloid Leukemia
Kiyomi Morita et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Consequences of mutant TET2 on clonality and subclonal hierarchy
Cassandra M. Hirsch et al.
LEUKEMIA (2018)
Persistence of pre-leukemic clones during first remission and risk of relapse in acute myeloid leukemia
Maja Rothenberg-Thurley et al.
LEUKEMIA (2018)
RNA cytosine methylation and methyltransferases mediate chromatin organization and 5-azacytidine response and resistance in leukaemia
Jason X. Cheng et al.
NATURE COMMUNICATIONS (2018)
Cytogenetics and gene mutations influence survival in older patients with acute myeloid leukemia treated with azacitidine or conventional care
Hartmut Doehner et al.
LEUKEMIA (2018)
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
Hartmut Doehner et al.
BLOOD (2017)
Response to 5-azacytidine in a patient with TET2-mutated angioimmunoblastic T-cell lymphoma and chronic myelomonocytic leukaemia preceded by an EBV-positive large B-cell lymphoma
Colombe Saillard et al.
HEMATOLOGICAL ONCOLOGY (2017)
Genomic determinants of chronic myelomonocytic leukemia
B. J. Patel et al.
LEUKEMIA (2017)
Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a FLT3 Mutation
R. M. Stone et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Combination Targeted Therapy to Disrupt Aberrant Oncogenic Signaling and Reverse Epigenetic Dysfunction in IDH2- and TET2-Mutant Acute Myeloid Leukemia
Alan H. Shih et al.
CANCER DISCOVERY (2017)
Mutations in the DNA methylation pathway and number of driver mutations predict response to azacitidine in myelodysplastic syndromes
M. Teresa Cedena et al.
ONCOTARGET (2017)
Prognostic role of TET2 deficiency in myelodysplastic syndromes: A meta-analysis
Yun Lin et al.
ONCOTARGET (2017)
Myeloid malignancies in the real-world: Occurrence, progression and survival in the UK's population-based Haematological Malignancy Research Network 2004-15
Eve Roman et al.
CANCER EPIDEMIOLOGY (2016)
Genomic Classification and Prognosis in Acute Myeloid Leukemia
Elli Papaemmanuil et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Mutational Cooperativity Linked to Combinatorial Epigenetic Gain of Function in Acute Myeloid Leukemia
Alan H. Shih et al.
CANCER CELL (2015)
Adverse prognostic effect of homozygous TET2 mutation on the relapse risk of acute myeloid leukemia in patients of normal karyotype
Jae-Sook Ahn et al.
HAEMATOLOGICA (2015)
Association Between Mutation Clearance After Induction Therapy and Outcomes in Acute Myeloid Leukemia
Jeffery M. Klco et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)
limma powers differential expression analyses for RNA-sequencing and microarray studies
Matthew E. Ritchie et al.
NUCLEIC ACIDS RESEARCH (2015)
Acute myeloid leukemia cells MOLM-13 and SKM-1 established for resistance by azacytidine are crossresistant to P-glycoprotein substrates
Lucia Messingerova et al.
TOXICOLOGY IN VITRO (2015)
Adverse prognostic effect of homozygous TET2 mutation on the relapse risk of acute myeloid leukemia in patients of normal karyotype
Jae-Sook Ahn et al.
HAEMATOLOGICA (2015)
Efficacy of 5-Azacytidine in a TET2 mutated angioimmunoblastic T cell lymphoma
Morgane Cheminant et al.
BRITISH JOURNAL OF HAEMATOLOGY (2015)
Minfi: a flexible and comprehensive Bioconductor package for the analysis of Infinium DNA methylation microarrays
Martin J. Aryee et al.
BIOINFORMATICS (2014)
TET2 mutations predict response to hypomethylating agents in myelodysplastic syndrome patients
Rafael Bejar et al.
BLOOD (2014)
TET2 Mutations in Cytogenetically Normal Acute Myeloid Leukemia: Clinical Implications and Evolutionary Patterns
Frederik Damm et al.
GENES CHROMOSOMES & CANCER (2014)
Prognostic significance of Tet methylcytosine dioxygenase 2 (TET2) gene mutations in adult patients with acute myeloid leukemia: a meta-analysis
Wen-Jian Liu et al.
LEUKEMIA & LYMPHOMA (2014)
Preleukemic mutations in human acute myeloid leukemia affect epigenetic regulators and persist in remission
M. Ryan Corces-Zimmerman et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Phenotypic and genotypic characterization of azacitidine-sensitive and resistant SKM1 myeloid cell lines
Thomas Cluzeau et al.
ONCOTARGET (2014)
Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2
Michael I. Love et al.
GENOME BIOLOGY (2014)
STAR: ultrafast universal RNA-seq aligner
Alexander Dobin et al.
BIOINFORMATICS (2013)
Sequential azacitidine plus lenalidomide combination for elderly patients with untreated acute myeloid leukemia
Daniel A. Pollyea et al.
HAEMATOLOGICA (2013)
Azacytidine and erlotinib exert synergistic effects against acute myeloid leukemia
E. Lainey et al.
ONCOGENE (2013)
Erlotinib antagonizes ABC transporters in acute myeloid leukemia
Elodie Lainey et al.
CELL CYCLE (2012)
TET2 Mutations in Acute Myeloid Leukemia (AML): Results From a Comprehensive Genetic and Clinical Analysis of the AML Study Group
Verena I. Gaidzik et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Landscape of TET2 mutations in acute myeloid leukemia
S. Weissmann et al.
LEUKEMIA (2012)
Prognostic Relevance of Integrated Genetic Profiling in Acute Myeloid Leukemia
Jay P. Patel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Gene mutation patterns and their prognostic impact in a cohort of 1185 patients with acute myeloid leukemia
Yang Shen et al.
BLOOD (2011)
Deletion of Tet2 in mice leads to dysregulated hematopoietic stem cells and subsequent development of myeloid malignancies
Zhe Li et al.
BLOOD (2011)
Tet2 Loss Leads to Increased Hematopoietic Stem Cell Self-Renewal and Myeloid Transformation
Kelly Moran-Crusio et al.
CANCER CELL (2011)
TET2 Mutations Improve the New European LeukemiaNet Risk Classification of Acute Myeloid Leukemia: A Cancer and Leukemia Group B Study
Klaus H. Metzeler et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
The Interlaboratory RObustness of Next-generation sequencing (IRON) study: a deep sequencing investigation of TET2, CBL and KRAS mutations by an international consortium involving 10 laboratories
A. Kohlmann et al.
LEUKEMIA (2011)
Impact of TET2 mutations on response rate to azacitidine in myelodysplastic syndromes and low blast count acute myeloid leukemias
R. Itzykson et al.
LEUKEMIA (2011)
A framework for variation discovery and genotyping using next-generation DNA sequencing data
Mark A. DePristo et al.
NATURE GENETICS (2011)
Metabolism unhinged: IDH mutations in cancer
John R. Prensner et al.
NATURE MEDICINE (2011)
WT1 mutation in 470 adult patients with acute myeloid leukemia: stability during disease evolution and implication of its incorporation into a survival scoring system
Hsin-An Hou et al.
BLOOD (2010)
Incidence and prognostic value of TET2 alterations in de novo acute myeloid leukemia achieving complete remission
Olivier Nibourel et al.
BLOOD (2010)
Leukemic IDH1 and IDH2 Mutations Result in a Hypermethylation Phenotype, Disrupt TET2 Function, and Impair Hematopoietic Differentiation
Maria E. Figueroa et al.
CANCER CELL (2010)
Genetic characterization of TET1, TET2, and TET3 alterations in myeloid malignancies
Omar Abdel-Wahab et al.
BLOOD (2009)
Acquired mutations in TET2 are common in myelodysplastic syndromes
Saskia M. C. Langemeijer et al.
NATURE GENETICS (2009)
Mutation in TET2 in Myeloid Cancers
Francois Delhommeau et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Development of a human adaptive immune system in cord blood cell-transplanted mice
E Traggiai et al.
SCIENCE (2004)
分享论文
